Effects of primer components of silane and 10-methacryloyloxydecyl dihydrogen phosphate on resin bonding to tribochemical silica-coated highly translucent zirconia
Clinical Oral Investigations · 2024
DOI: 10.1007/s00784-024-06024-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Oral Investigations, 2024. Verfasst von Fumika Tsuda und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Prosthodontics, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1, Sakamoto, Nagasaki, 852-8588, Japan. Hauptthemen laut MEDLINE: Zirconium, Methacrylates, Resin Cements, Dental Bonding. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Prosthodontics, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1, Sakamoto, Nagasaki, 852-8588, Japan.
- Clinic of Fixed Prosthodontics, Nagasaki University Hospital, 1-7-1, Sakamoto, Nagasaki, 852-8588, Japan. keiichi@nagasaki-u.ac.jp.
Zitieren
APA
Tsuda, F., Yoshida, K., & Sawase, T. (2024). Effects of primer components of silane and 10-methacryloyloxydecyl dihydrogen phosphate on resin bonding to tribochemical silica-coated highly translucent zirconia. Clinical Oral Investigations. https://doi.org/10.1007/s00784-024-06024-3
Vancouver
Tsuda F, Yoshida K, Sawase T. Effects of primer components of silane and 10-methacryloyloxydecyl dihydrogen phosphate on resin bonding to tribochemical silica-coated highly translucent zirconia. Clinical Oral Investigations. 2024. doi:10.1007/s00784-024-06024-3
BibTeX
@article{Tsuda2024,
author = {Tsuda, Fumika and Yoshida, Keiichi and Sawase, Takashi},
title = {Effects of primer components of silane and 10-methacryloyloxydecyl dihydrogen phosphate on resin bonding to tribochemical silica-coated highly translucent zirconia},
journal = {Clinical Oral Investigations},
year = {2024},
doi = {10.1007/s00784-024-06024-3}
}
EUVIMED